The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 05, 2019

Filed:

Nov. 11, 2014
Applicant:

Georgia Tech Research Corporation, Atlanta, GA (US);

Inventors:

Thomas H. Barker, Atlanta, GA (US);

Ashley Carson Brown, Atlanta, GA (US);

Louis Andrew Lyon, Irvine, CA (US);

Sarah E. Stabenfeldt, Tempe, AZ (US);

Nicole Welsch, Berlin, DE;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); A61L 24/00 (2006.01); A61L 27/22 (2006.01); A61L 26/00 (2006.01); A61L 24/04 (2006.01); A61L 24/06 (2006.01);
U.S. Cl.
CPC ...
A61L 24/0015 (2013.01); A61L 24/046 (2013.01); A61L 24/06 (2013.01); A61L 26/0047 (2013.01); A61L 27/227 (2013.01); A61L 2300/418 (2013.01); A61L 2400/04 (2013.01);
Abstract

Ultra-low crosslinked microgels made of an ultra-low crosslinked polymer are provided. The microgels, also referred to as Platelet-like Particles (PLPs), preferably have <0.5% crosslinking densities. One or more of the polymers are conjugated with a fibrin-binding element or moiety, preferably H6, in an amount effective to confer to the microgel selective binding to fibrin under physiological conditions. The PLPs can recapitulate multiple key functions of platelets including binding, stabilizing and enhancing fibrin clot formation, responsiveness to injury cues, and induction of clot contraction. In a preferred embodiment, the microgel or PLP has little or no binding to soluble fibrinogen under physiological conditions compared to its binding to fibrin. The microgels or PLPs are prepared using crosslinker-free synthesis conditions, and can promote or induce clotting and clot contraction.


Find Patent Forward Citations

Loading…